Sophie Strobl

Ms. Sophie Strobl

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2024 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
GSGudrun Salamon
Gudrun Salamon
UFUrsula Field-Werners
Ursula Field-Werners
SSSophie Strobl
Sophie Strobl
VHVinzenz Hübl
Vinzenz Hübl
ADAnja Diem
Anja Diem
Background: With approximately 500 people affected in Austria, epidermolysis bullosa (EB) is a rare genetic skin disease reducing the quality of life of those affected and their relatives. The intensive efforts of the patient organisation DEBRA Austria during the last decades have led to a unique situation of those affected and their relatives, with increased support and broader knowledge about the disease in the general population. The aim of the study is to evaluate the current situation of patients and their relatives living in Austria, with a focus on burdens and helpful practices. Results: The mixed-methods study consisted of two parts: a qualitative interview study to identify psychosocial aspects of EB in those affected and their relatives, and a subsequent online survey to further assess those aspects in a larger sample, resulting in a total of n=78 Austrian participants. The impact of EB on the quality of life of EB patients and their relatives in Austria is related to the current health status, psychological burden, mobility, visibility, financial situation as well as job prospects. Personal and social resources and external support have a significant influence on the individual situation. Conclusions: The outcome is mapped to concrete implications regarding targeted support for EB patients and their relatives on an individual level and their needs in regard to the Austrian health care system.

23 January 2024 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
GSGudrun Salamon
Gudrun Salamon
SSSophie Strobl
Sophie Strobl
UFUrsula Field-Werners
Ursula Field-Werners
ADAnja Diem
Anja Diem
ASAgnes Schwieger-Briel
Agnes Schwieger-Briel
EPElena Pope
Elena Pope
In contrast to clinical diagnosis via external examination, patient-related outcome measures allow to access the patients’ internal perception. Particularly, in the case of epidermolysis bullosa (EB), a rare disease characterized by a wide variety of symptoms and individual courses of disease, it is central to integrate the patient’s perspective into diagnostic processes. The Instrument for Scoring Clinical Outcome of Research for EB (iscorEB) is an EB-specific measurement tool, combining a clinician score (iscorEB-c) and a patient questionnaire (iscorEB-p). The aim of this study is to establish the iscorEB-p as an independent patient-related outcome measure tool by exploring its psychometric properties. The following steps were performed on data collected via a multinational online cross-sectional study: sample-based psychometric testing and evaluation. Data analysis was performed with n=95 participants across all EB types. The reliability and internal consistency of the iscorEB-p was excellent (α=0.90). A principal component analysis with a varimax rotation resulted in a two-factor solution, explaining 55.6% of the total variance, with the distinct factors “everyday life functioning” and “specific EB symptoms”. Convergent validity was shown by high correlations to the SWLS (r=-0.52, p<0.001), the QOLEB (r=0.72, p<0.001) and EB-BoD (r=-0.73, p<0.001). In conclusion, the iscorEB-p is a reliable and valid instrument to assess the patient-reported view on the health status of EB patients.

21 June 2024 in Health Expectations
Verified
Journal Article
Open access
GSGudrun Salamon
Gudrun Salamon
UFUrsula Field‐Werners
Ursula Field‐Werners
SSSophie Strobl
Sophie Strobl
VHVinzenz Hübl
Vinzenz Hübl
ADAnja Diem
Anja Diem
Objective: Although Ireland has one of the highest levels of well‐being in Europe, having a health condition has been found to have a direct negative impact. The aim of this study is to evaluate the current situation and the experiences of patients with epidermolysis bullosa (EB), a rare genetic skin disease, and their relatives living in Ireland, with a focus on burdens and helpful practices.Methods and Measures: In a mixed‐methods design, a series of standardised questionnaires were combined with open‐ended questions. Via an online survey, data from n = 59 EB patients and relatives of EB patients living in Ireland were collected.Results: EB affects both the patients and their relatives. Burdens were found in relation to the visibility of EB, the degree of severity, the current health status, reduced mobility, the financial impact of EB, the psychosocial impact and personal and social resources. The paper also analyses existing resources and highlights opportunities for support and needs of improvement.Conclusion: Quality of life with EB is influenced by somatic symptoms and the psychosocial burden. Individual helpful practices in dealing with this rare disease can be considered as mediators, but they need to be supported by structural and healthcare improvements.Patient or Public Contribution: The perspective of EB patients, their relatives and EB experts were taken into account in the development of the study design via two feedback loops with the EB patient organisations DEBRA Ireland and DEBRA Austria. The design was adapted accordingly. Additionally, by including open‐ended questions, patients and relatives could contribute their individual perspectives and add insights into their lives with EB that might not have been captured with the structured online survey alone.

23 March 2026 in British Journal of Dermatology
Verified
Journal Article
Closed access
CPChristian Puttinger
Christian Puttinger
GHGretha Hecke
Gretha Hecke
SSSophie Strobl
Sophie Strobl
PHPetra Hitthaler-Waigner
Petra Hitthaler-Waigner
TWTobias Welponer
Tobias Welponer
GSGudrun Salamon
Gudrun Salamon
Pain is one of the most burdensome symptoms for patients with Epidermolysis bullosa (EB), and due to the disease heterogeneity, pain management requires an individualized approach. This meta-analysis identified nine studies of those four topical and one systemic study showed a significant improvement in pain scores. The variety of different tools used for measuring pain underscore the importance to foster harmonisation in patient reported outcomes measurement tools, especially in pain.

4 June 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
SVSebastián Véliz
Sebastián Véliz
GSGudrun Salamon
Gudrun Salamon
MKMilica Kabic
Milica Kabic
SSSophie Strobl
Sophie Strobl
PDPedro Diz
Pedro Diz
SKSusanne Krämer
Susanne Krämer
Introduction: Epidermolysis Bullosa (EB) is a rare genetic condition with skin and mucosal fragility. Patients with EB present extra- and intraoral manifestations that can limit their access to dental treatment, including orthodontic treatment. This research aims to determine the barriers, benefits and complications of orthodontic treatment reported by a group of patients living with EB. Materials and Methods: This observational study included n = 101 patients with a genetic diagnosis of EB. After their regular dental consultation, they were interviewed about factors they considered barriers to accessing orthodontic treatment. Those who underwent orthodontic treatment (n = 24) reflected about their perceived benefits and complications from the therapy. Data were analysed with descriptive statistics and multiple Fisher’s exact tests with false discovery rate (FDR) correction. Results: The most prevalent barrier was that most patients with EB had never been evaluated by an orthodontist (74.3%), even if the teams had an orthodontist. Other barriers included distance to the treatment centre (42.6%), poor oral hygiene (27.7%) and poor oral health status (26.7%). Patients with limited mouth opening perceived greater treatment benefit compared to those without this limitation (φ = −0.28, p = 0.0242), while an increasing age was associated with a reduced perception of treatment benefit (Cramér’s V = 0.29, p = 0.0404). Among those who underwent orthodontic treatment, the most prevalent benefits of orthodontic treatment were aesthetic improvement (62.5%), oral hygiene improvement (20.8%) and occlusal stability (12.5%), while the most prevalent complications were wounds and ulcers (75.0%), gingivitis (54.1%), poor oral hygiene (41.6%) and caries (33.3%). Discussion: People living with EB reported different barriers to orthodontic treatment relating to psychosocial and professional aspects, which vary according to the EB type and severity. The involvement of orthodontists in multidisciplinary special care teams and the reduction in access barriers to dental specialities can be facilitated by a more comprehensive understanding of conditions such as EB.

29 June 2026 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
GZGiovanna Zambruno
Giovanna Zambruno
TSTonia Samela
Tonia Samela
ADAndrea Diociaiuti
Andrea Diociaiuti
GSGudrun Salamon
Gudrun Salamon
SSSophie Strobl
Sophie Strobl
MHMay El Hachem
May El Hachem
Inherited epidermolysis bullosa comprises a heterogeneous group of skin fragility diseases, presenting with a range of manifestations and complications that profoundly affect quality of life (QoL). A disease-specific instrument, Quality of Life in EB (QOLEB), has been developed to assess the impact of epidermolysis bullosa signs and symptoms on QoL. The aim of this cross sectional study, conducted as part of a European project – BUR-EB, was to test the psychometric properties of the Italian version of the QOLEB and to assess QoL in Italian epidermolysis bullosa patients. Demographic, clinical, and QOLEB data of 56 Italian patients aged ≥11 years participating in the BUR-EB online survey were analysed. Principal component analysis showed excellent internal consistency of Italian QOLEB, and high convergent validity with the generic questionnaire EQ-5D. About 40% of patients reported severe to very severe disease burden, and a strong correlation was observed between disease severity and QOLEB scores. Independent variables associated with worse QoL were pain, chronic wounds, wheelchair use and patient organization membership. Our study confirms the good psychometric properties of the Italian QOLEB. In addition to depicting the major impact of epidermolysis bullosa on QoL, it identifies pain, chronic wounds and functional disability as major targets for therapeutic interventions.